diphenylamine has been researched along with Urinary Bladder Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domany, E; Eichhorn, PJA; Ha, HK; Haviv-Shapira, L; Iyengar, PV; Jaynes, PW; Kappei, D; Kumar, AP; Lama, D; Lui, SKL; Ng, HC; Radulescu, C; Rouanne, M; Saei, A; Sim, WJ; Tan, TZ; Ten Dijke, P; Thiery, JP; Verma, CS | 1 |
| Andresen, CJ; Bagi, CM; Cirone, P; Eswaraka, JR; Lappin, PB | 1 |
| El-Bayoumy, K; Fiala, ES; Kulkarni, B; Nussbaum, M; Weisburger, JH | 1 |
| Chandrasekaran, V; Katayama, S; Weisburger, JH; Williams, GM | 1 |
| Chandrasekaran, V; Fiala, ES; Katayama, S; Weisburger, JH; Williams, GM | 1 |
| Genin, VA | 1 |
6 other study(ies) available for diphenylamine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression.
Topics: Animals; Benzamides; Cell Line, Tumor; Diphenylamine; Disease Progression; Epithelial-Mesenchymal Transition; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Kaplan-Meier Estimate; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-met; Pyrazoles; Quinolines; Receptors, Transforming Growth Factor beta; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer.
Topics: Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Diphenylamine; Disease Models, Animal; Female; Humans; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred NOD; Mice, SCID; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Random Allocation; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2014 |
In vivo metabolism of 3,2'-dimethyl-4-aminobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the F344 rat.
Topics: Aminobiphenyl Compounds; Aniline Compounds; Animals; Bile; Binding Sites; Carcinogens; Chromatography, Thin Layer; Cricetinae; Diphenylamine; Glucuronates; Intestinal Neoplasms; Male; Mass Spectrometry; Mesocricetus; Neoplasms, Experimental; Organ Specificity; Rats; Rats, Inbred F344; Species Specificity; Urinary Bladder Neoplasms | 1983 |
Carcinogenicity of 3-methyl-2-naphthylamine and 3,2'-dimethyl-4-aminobiphenyl to the bladder and gastrointestinal tract of the Syrian golden hamster with atypical proliferative enteritis.
Topics: 2-Naphthylamine; Adenocarcinoma; Aminobiphenyl Compounds; Aniline Compounds; Animals; Carcinogens; Carcinoma, Transitional Cell; Cricetinae; Diphenylamine; Enteritis; Gastrointestinal Neoplasms; Male; Mesocricetus; Naphthalenes; Neoplasms, Experimental; Time Factors; Urinary Bladder Neoplasms | 1981 |
The effect of disulfiram on the carcinogenicity of 3,2'dimethyl-4-aminopbiphenyl in Syrian golden hamsters and rats.
Topics: Aminobiphenyl Compounds; Aniline Compounds; Animals; Carcinogens; Cricetinae; Diphenylamine; Disulfiram; Drug Interactions; Male; Mesocricetus; Neoplasms, Experimental; Rats; Species Specificity; Urinary Bladder Neoplasms | 1981 |
[Formation of blastomogenic diphenylamino derivatives as a result of the metabolism of Direct azo dyes].
Topics: Aniline Compounds; Azo Compounds; Benzidines; Carcinogens; Chemical Industry; Coloring Agents; Dianisidine; Diphenylamine; Environmental Exposure; Humans; Occupational Diseases; Time Factors; Urinary Bladder Neoplasms; USSR | 1977 |